Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: art slott who wrote (2868)	1/11/1999 7:58:00 AM
From: Thai Chung	Respond to of 3725

Monday January 11, 7:03 am Eastern Time **With the dollar is dropped substantially, hope this would also boost international sales as well. Good luck to all. Company Press Release Imatron Announces Ultrafast CT Scanner Shipment to Hackensack University Medical Center "Mammogram of the Heart" Utilizing Imatron's Ultrafast CT(R) Featured on NBC Nightly News With Tom Brokaw SOUTH SAN FRANCISCO, Calif.--(BW HealthWire)--Jan. 11, 1999-- Imatron Inc. (Nasdaq: IMAT - news) announced today that it has shipped an Ultrafast CT scanner to Hackensack University Medical Center in Hackensack, New Jersey. Shipment of Imatron's Ultrafast CT scanner will be recognized as a sale in the company's fourth fiscal quarter. Hackensack University Medical Center is a leading teaching hospital affiliated with the University of Medicine and Dentistry of New Jersey -- New Jersey Medical School. It is the largest provider of inpatient and outpatient services in the state of New Jersey and is the only hospital in New Jersey to be nationally ranked by U.S. News and World Report's ''America's Best Hospitals'' in six specialties, including cardiology. Louis Evan Teichholz, M.D., Medical Director of Cardiac Services and Chief of Cardiology, said, ''Hackensack University Medical Center historically has made a strong commitment to providing leading-edge technology and services for the community that it serves. The addition of the state-of-the-art, innovative technology offered by the Ultrafast CT scanner to our Heart Center will allow early detection of heart disease and improve our ability to provide the highest quality cardiac services to all of our patients.'' S. Lewis Meyer, Imatron's President and CEO, said, ''The announcement of this sale to Hackensack University Medical Center further validates our Ultrafast CT technology. We are looking forward to working with the outstanding clinical staff at Hackensack University Medical Center to help us accelerate electron beam tomography technology forward into exciting new areas of clinical applications. We believe these continued votes of confidence in electron beam tomography technology by such nationally-recognized institutions such as Hackensack University Medical Center will form the foundation for increased system sales in 1999.'' Meyer continued, ''Along with validation of our electron beam computed tomography (EBCT) technology through sales of Imatron's Ultrafast CT scanner, our proprietary technology continues to receive scientific and media validation with the recent publication of two groundbreaking papers in the December 31, 1998 issue of The New England Journal of Medicine supporting important EBCT applications in cardiology, and a January 1, 1999 Mayo Clinic study supporting the crucial role and potential cost-saving benefits of Ultrafast CT in the evaluation of Emergency Room chest pain patients. The New England Journal of Medicine's two studies on EBCT received prominent exposure in the January 11, 1999 issue of Time Magazine's cover story, 'The Future of Medicine' and, most recently, on January 7, 1999, NBC Nightly News with Tom Brokaw featured the Ultrafast CT scanner with medical experts characterizing the Coronary Artery Scan as the 'mammogram of the heart.''' Imatron, Inc. is primarily engaged in designing, manufacturing, marketing, and supporting high performance computed tomography (CT) scanners based on the Company's proprietary scanning electron beam technology. Ultrafast CT is a registered trademark of Imatron. Imatron's Ultrafast CT scanner is now in use at major medical centers around the world, including The Mayo Clinic, University of Iowa, National Institutes of Health, UCLA, Stanford University, University of Illinois, The Arizona Heart Institute, The Royal Brompton Hospital in London, Tokyo University Hospital and Beijing Hospital. Except for the historical information contained herein, the matters discussed in this news release may contain forward-looking statements that are based on current expectations and estimates about the industry in which Imatron operates, the estimated impact of certain technological advances, the estimated impact of published research studies on scanner sales and procedures, as well as management's beliefs and assumptions. It is important to note that the Company's actual results could differ materially from those projected in such forward-looking statements. The factors that could cause actual results to differ materially include, among others: failed clinical demonstration of certain asserted technological advantages and diagnostic capabilities; reliance on product distributors; competition in the diagnostic imaging market; failure to improve product reliability or introduce new product models and enhancements; delays in production and difficulty in obtaining components and sub-assemblies from limited sources of supply; inability to meet cash-on-delivery or prepayment terms from vendors; determinations by regulatory and administrative government authorities; patent expiration and denial of patent applications; the high cost of the scanner as compared to commercially available CT scanners; and the risk factors listed from time to time in the Company's Securities and Exchange Commission reports, including their reports on Form 10-K for their current fiscal year.